In contrast, treatment of NSCLC cells for 24 h with increasing doses of BTZ (32–128 nM) highly induced the level of HSPA1 and substantially decreased the level of HSPA2, without affecting the expression of HSPA5 and HSPA8 (Fig. 1E). Here, CASC3 is linked to non-small cell lung carcinoma.